arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

XOMA Royalty Corp

XOMA
$40.32 0.00 (0.00%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
67 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
66
Health
Good
Moderately Bullish
auto_awesome

Analytical Summary

XOMA Royalty Corp shows strong fundamentals with top-quartile Return on Common Equity (%) and Profit Margin (%). However, watch Debt to Equity which shows concerning trends. Overall, the data suggests a moderately positive outlook with manageable risks.

Market Cap $479.6M
Dividend Yield
Revenue Growth -22.6%
Op. Margin -3.9%
ROIC -0.3%
FCF / Share $0.51
Trailing P/E 224.0x
Price / Book 5.2x
FCF Yield 1.3%
Debt / Equity 0.96
info Valuation on last close. End-of-day price, Jul 13, 2026.

67-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$12.32M
↓ -22.6%
Net Income Profit after all expenses
$4.46M
↑ +88.6%
Operating Margin Operating profit as % of sales
-3.9%
↓ -124.6% 78th
FCF / Share Free cash flow per share
$0.51
↑ +180.2%
Long-Term Debt Long-term obligations
$88.83M
↓ -7.9%
trending_up

Bullish Indicators

  • Operating Margin (%)Operating Margin (%) is in the top quartile
  • Profit Margin (%)Profit Margin (%) is in the top quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • Debt to EquityDebt to Equity is concerning (bottom quartile)

Health Breakdown

Profitability
74
Returns
95
Financial Health
39
Cash Quality
25

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 18 years · 67 quarters